RXO Forecast, price target & analysts
RXO Target price 2025 - Analyst rating & recommendation
RXO Classifications & Recommendation:
RXO Price Target
| Target Price | $21.89 |
| Price | $18.92 |
| Potential |
15.72%
register free of charge
|
| Number of Estimates | 19 |
|
19 Analysts have issued a price target RXO 2026 .
The average RXO target price is $21.89.
This is
15.72%
register free of charge
$26.00
37.42%
register free of charge
$13.00
31.29%
register free of charge
|
|
| A rating was issued by 21 analysts: 5 Analysts recommend RXO to buy, 13 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the RXO stock has an average upside potential 2026 of
15.72%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 4.55 | 6.60 |
| 15.86% | 45.11% | |
| EBITDA Margin | 2.57% | 2.70% |
| 24.64% | 5.00% | |
| Net Margin | -7.75% | -0.05% |
| 6,342.92% | 99.35% |
18 Analysts have issued a sales forecast RXO 2025 . The average RXO sales estimate is
This results in the following potential growth metrics:
19 Analysts have issued an RXO EBITDA forecast 2025. The average RXO EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
13 RXO Analysts have issued a net profit forecast 2025. The average RXO net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -2.17 | -0.02 |
| 7,333.33% | 99.08% | |
| P/E | negative | |
| EV/Sales | 0.56 |
13 Analysts have issued a RXO forecast for earnings per share. The average RXO EPS is
This results in the following potential growth metrics and future valuations:
Current RXO Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Wells Fargo |
Locked
➜
Locked
|
Locked | Mar 27 2025 |
| Susquehanna |
Locked
➜
Locked
|
Locked | Mar 26 2025 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Mar 13 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Feb 06 2025 |
| Stifel |
Locked
➜
Locked
|
Locked | Feb 06 2025 |
| Goldman Sachs |
Locked
➜
Locked
|
Locked | Feb 06 2025 |
| Stifel |
Locked
➜
Locked
|
Locked | Jan 23 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Mar 27 2025 |
|
Locked
Susquehanna:
Locked
➜
Locked
|
Mar 26 2025 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Mar 13 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Feb 06 2025 |
|
Locked
Stifel:
Locked
➜
Locked
|
Feb 06 2025 |
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Feb 06 2025 |
|
Locked
Stifel:
Locked
➜
Locked
|
Jan 23 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
